CA2247041A1 - Milieu de contraste - Google Patents
Milieu de contraste Download PDFInfo
- Publication number
- CA2247041A1 CA2247041A1 CA002247041A CA2247041A CA2247041A1 CA 2247041 A1 CA2247041 A1 CA 2247041A1 CA 002247041 A CA002247041 A CA 002247041A CA 2247041 A CA2247041 A CA 2247041A CA 2247041 A1 CA2247041 A1 CA 2247041A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- modifier
- osmotic
- viscosity
- viscosity modifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002872 contrast media Substances 0.000 title claims abstract description 54
- 239000003607 modifier Substances 0.000 claims abstract description 49
- 230000003204 osmotic effect Effects 0.000 claims abstract description 35
- 239000004034 viscosity adjusting agent Substances 0.000 claims abstract description 33
- 239000011248 coating agent Substances 0.000 claims abstract description 31
- 238000000576 coating method Methods 0.000 claims abstract description 31
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 20
- 210000003750 lower gastrointestinal tract Anatomy 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 114
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical group [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 46
- 238000003384 imaging method Methods 0.000 claims description 37
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 20
- 230000000112 colonic effect Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 10
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 238000002604 ultrasonography Methods 0.000 claims description 7
- 210000004877 mucosa Anatomy 0.000 claims description 6
- 229920001206 natural gum Polymers 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 150000002170 ethers Chemical class 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 230000003232 mucoadhesive effect Effects 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 238000012377 drug delivery Methods 0.000 claims description 2
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 5
- 239000007900 aqueous suspension Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 description 49
- 210000001072 colon Anatomy 0.000 description 28
- 241000282472 Canis lupus familiaris Species 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 235000010980 cellulose Nutrition 0.000 description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 11
- 239000001913 cellulose Substances 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 229920002678 cellulose Polymers 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 238000009877 rendering Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000004302 potassium sorbate Substances 0.000 description 7
- 235000010241 potassium sorbate Nutrition 0.000 description 7
- 229940069338 potassium sorbate Drugs 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 229940083037 simethicone Drugs 0.000 description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 7
- 229920003091 Methocel™ Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000001174 ascending effect Effects 0.000 description 6
- 229910052788 barium Inorganic materials 0.000 description 6
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 6
- 229940039231 contrast media Drugs 0.000 description 6
- 235000010234 sodium benzoate Nutrition 0.000 description 6
- 239000004299 sodium benzoate Substances 0.000 description 6
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 229940105329 carboxymethylcellulose Drugs 0.000 description 5
- 229940031705 hydroxypropyl methylcellulose 2910 Drugs 0.000 description 5
- 229940085605 saccharin sodium Drugs 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000207199 Citrus Species 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 229960004543 anhydrous citric acid Drugs 0.000 description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 4
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- -1 methylcarboxyethyl Chemical group 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 229920002359 Tetronic® Polymers 0.000 description 3
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000002059 diagnostic imaging Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 238000011833 dog model Methods 0.000 description 3
- 229940051147 fd&c yellow no. 6 Drugs 0.000 description 3
- 238000002594 fluoroscopy Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 3
- 238000011176 pooling Methods 0.000 description 3
- 229920000945 Amylopectin Polymers 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010073306 Exposure to radiation Diseases 0.000 description 2
- 229920003094 Methocel™ K4M Polymers 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002534 Polyethylene Glycol 1450 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 229920006184 cellulose methylcellulose Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013170 computed tomography imaging Methods 0.000 description 2
- 210000001731 descending colon Anatomy 0.000 description 2
- 210000004921 distal colon Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229940095399 enema Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 238000002603 single-photon emission computed tomography Methods 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000003384 transverse colon Anatomy 0.000 description 2
- 238000002609 virtual colonoscopy Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 101100114828 Drosophila melanogaster Orai gene Proteins 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010056626 Pseudopolyp Diseases 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 210000001815 ascending colon Anatomy 0.000 description 1
- 150000001553 barium compounds Chemical class 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- NPUACKRELIJTFM-UHFFFAOYSA-N cr gas Chemical compound C1=NC2=CC=CC=C2OC2=CC=CC=C21 NPUACKRELIJTFM-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002593 electrical impedance tomography Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- SQORATIMOBOFKR-UHFFFAOYSA-H gadolinium(3+);oxalate Chemical compound [Gd+3].[Gd+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O SQORATIMOBOFKR-UHFFFAOYSA-H 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000193 iodinated contrast media Substances 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000005404 magnetometry Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000002907 paramagnetic material Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920001987 poloxamine Polymers 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 208000022131 polyp of large intestine Diseases 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0404—X-ray contrast preparations containing barium sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne un milieu de contraste, capable de bien se déposer sur la partie inférieure du tube digestif, après une administration par voie orale. Le milieu comprend une quantité suffisante d'agent de contraste pour pouvoir effectuer les diagnostics requis, en combinaison avec un modificateur de viscosité et un modificateur osmotique, ces deux modificateurs étant présents tous deux en une proportion pondérale par rapport audit agent d'au moins 1:20.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9603547.2 | 1996-02-20 | ||
GBGB9603547.2A GB9603547D0 (en) | 1996-02-20 | 1996-02-20 | Contrast media |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2247041A1 true CA2247041A1 (fr) | 1997-08-28 |
Family
ID=10789076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002247041A Abandoned CA2247041A1 (fr) | 1996-02-20 | 1997-02-20 | Milieu de contraste |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0881916A2 (fr) |
JP (1) | JP2000504742A (fr) |
KR (1) | KR19990087196A (fr) |
CN (1) | CN1215342A (fr) |
AU (1) | AU1885297A (fr) |
BR (1) | BR9710946A (fr) |
CA (1) | CA2247041A1 (fr) |
GB (1) | GB9603547D0 (fr) |
HU (1) | HUP9901323A2 (fr) |
NO (1) | NO983828L (fr) |
WO (1) | WO1997030736A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6928314B1 (en) | 1998-01-23 | 2005-08-09 | Mayo Foundation For Medical Education And Research | System for two-dimensional and three-dimensional imaging of tubular structures in the human body |
DE19844495B4 (de) * | 1998-09-29 | 2005-04-07 | Man Roland Druckmaschinen Ag | Verfahren zur Farbkalibrierung mittels Colormanagement für eine digital ansteuerbare Druckmaschine mit einer wiederbeschreibbaren Druckform |
JP3461750B2 (ja) | 1999-03-04 | 2003-10-27 | パナソニック コミュニケーションズ株式会社 | 通信装置、通信方法、および発信者情報の登録方法 |
AUPQ605500A0 (en) | 2000-03-07 | 2000-03-30 | Medefield Pty Ltd | Stool marker |
US7591998B2 (en) | 2000-03-07 | 2009-09-22 | Kevin Tait | Stool marker |
US6477401B1 (en) | 2000-03-10 | 2002-11-05 | Mayo Foundation For Medical Education And Research | Colonography of an unprepared colon |
WO2007030132A2 (fr) | 2005-02-14 | 2007-03-15 | Mayo Foundation For Medical Education And Research | Soustraction electronique des matieres fecales en colographie par tomographie par ordinateur |
US8043604B2 (en) * | 2007-04-27 | 2011-10-25 | Pluromed, Inc. | Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels |
EP3984560A1 (fr) | 2013-03-15 | 2022-04-20 | The Regents of the University of California | Matériel de contraste entérique pour tomographie assistée par ordinateur (ct) basée sur atomes z faibles |
CN117018234A (zh) * | 2013-08-16 | 2023-11-10 | 加利福尼亚大学董事会 | 硅酮基肠道ct对比材料 |
CN104587494A (zh) * | 2014-12-19 | 2015-05-06 | 张锐 | 一种胃肠钡餐造影配方及其制备方法 |
JP6415715B2 (ja) | 2015-09-30 | 2018-10-31 | デューク・ユニヴァーシティ | アスコルベート製剤及び造影剤としての使用方法 |
CN106075476B (zh) * | 2016-07-30 | 2019-05-31 | 温州市人民医院 | 一种造影剂 |
US20210186819A1 (en) * | 2018-09-07 | 2021-06-24 | Moore Dental Technologies And Solutions Llc | Dental Fracture Detection Compositions and Methods |
CN109540936A (zh) * | 2019-01-11 | 2019-03-29 | 大连大学附属中山医院 | 一种用于高分辨率ct及x线动脉、静脉或管道的室温造影剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55501057A (fr) * | 1978-12-19 | 1980-12-04 | ||
GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
US5352459A (en) * | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
WO1995022995A1 (fr) * | 1994-02-25 | 1995-08-31 | Nycomed Imaging A/S | Compositions de contraste radiologique contenant des derives de la cellulose |
-
1996
- 1996-02-20 GB GBGB9603547.2A patent/GB9603547D0/en active Pending
-
1997
- 1997-02-20 JP JP9529894A patent/JP2000504742A/ja active Pending
- 1997-02-20 CA CA002247041A patent/CA2247041A1/fr not_active Abandoned
- 1997-02-20 BR BR9710946-0A patent/BR9710946A/pt not_active Application Discontinuation
- 1997-02-20 KR KR1019980706591A patent/KR19990087196A/ko not_active Application Discontinuation
- 1997-02-20 CN CN97193663A patent/CN1215342A/zh active Pending
- 1997-02-20 WO PCT/GB1997/000473 patent/WO1997030736A2/fr not_active Application Discontinuation
- 1997-02-20 HU HU9901323A patent/HUP9901323A2/hu unknown
- 1997-02-20 EP EP97905227A patent/EP0881916A2/fr not_active Withdrawn
- 1997-03-20 AU AU18852/97A patent/AU1885297A/en not_active Abandoned
-
1998
- 1998-08-20 NO NO983828A patent/NO983828L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1215342A (zh) | 1999-04-28 |
JP2000504742A (ja) | 2000-04-18 |
AU1885297A (en) | 1997-09-10 |
NO983828L (no) | 1998-10-15 |
EP0881916A2 (fr) | 1998-12-09 |
NO983828D0 (no) | 1998-08-20 |
HUP9901323A2 (hu) | 1999-08-30 |
GB9603547D0 (en) | 1996-04-17 |
KR19990087196A (ko) | 1999-12-15 |
WO1997030736A3 (fr) | 1997-12-18 |
BR9710946A (pt) | 2000-10-31 |
WO1997030736A2 (fr) | 1997-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5593657A (en) | Barium salt formulations stabilized by non-ionic and anionic stabilizers | |
CA2247041A1 (fr) | Milieu de contraste | |
US5580579A (en) | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers | |
US5587143A (en) | Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions | |
US5466440A (en) | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays | |
RU2124886C1 (ru) | Частицы, включающие плохо растворимое кристаллическое терапевтическое или диагностическое средство, и способ их получения | |
WO1996020735A2 (fr) | Compositions orales a usage gastro-intestinal d'agents de contraste aux rayons x en combinaison avec des tensioactifs | |
CA2853520C (fr) | Purgatifs electrolytiques | |
NZ248727A (en) | Nanoparticles with x-ray contrast agent with high molecular weight surfactant adsorbed on the surface | |
US5318768A (en) | Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent | |
EP2968619B1 (fr) | Matériel de contraste entérique pour tomographie assistée par ordinateur (ct) basée sur atomes z faibles | |
US20200179539A1 (en) | Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation | |
US5342605A (en) | Polymeric X-ray compositions containing iodinated polymeric beads | |
US5352434A (en) | X-ray contrast compositions containing a barium salt and film-forming materials | |
US5525327A (en) | Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose | |
US5330740A (en) | Compositions of iodoaniline derivatives in film-forming materials for visualization of the gastrointestinal tract | |
JPH09512029A (ja) | 薬理学的に許容される粘土を含むx線造影組成物 | |
JPH0625016A (ja) | 皮膜形成物質を含有するx線造影組成物 | |
EP0746339A1 (fr) | Compositions de contraste radiologique contenant des derives de la cellulose | |
WO1994005336A1 (fr) | Compositions de contraste radiographiques filmogenes | |
Laerum et al. | Water-soluble contrast media compared with barium in enteric follow-through: local effects and radiographic efficacy in rats with simple obstruction of the small bowel | |
US5543132A (en) | X-ray contrast compositions containing a barium salt and a cellulose derivative | |
US5443814A (en) | X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives | |
US5258172A (en) | Iodinated aliphatic emulsions for X-ray contrast | |
US20010036442A1 (en) | Stool marker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |